Zimmer Biomet (ZBH) closed its previously-announced acquisition of Cayenne Medical, a manufacturer of soft tissue repair and reconstruction products for the knee, shoulder and extremities.
Cayenne’s portfolio includes the CrossFix® II to support an all-inside method for meniscal repair, the BioWick™ SureLock™ Interpositional Scaffold Wick for rotator cuff repair, the Mirror™ Partial Knee, etc.
The transaction is expected to bolster ZBH arthroscopy/soft tissue repair segment growth, alongside steady sales of Gel-One Hyaluronate and Subchondroplasty products. ORTHOWORLD estimates ZBH 1Q16 AR/ST revenue of $30.1MM, +0.4% vs. 1Q15, as-reported.
Zimmer Biomet (ZBH) closed its previously-announced acquisition of Cayenne Medical, a manufacturer of soft tissue repair and reconstruction products for the knee, shoulder and extremities.
Cayenne's portfolio includes the CrossFix® II to support an all-inside method for meniscal repair, the BioWick™ SureLock™ Interpositional...
Zimmer Biomet (ZBH) closed its previously-announced acquisition of Cayenne Medical, a manufacturer of soft tissue repair and reconstruction products for the knee, shoulder and extremities.
Cayenne’s portfolio includes the CrossFix® II to support an all-inside method for meniscal repair, the BioWick™ SureLock™ Interpositional Scaffold Wick for rotator cuff repair, the Mirror™ Partial Knee, etc.
The transaction is expected to bolster ZBH arthroscopy/soft tissue repair segment growth, alongside steady sales of Gel-One Hyaluronate and Subchondroplasty products. ORTHOWORLD estimates ZBH 1Q16 AR/ST revenue of $30.1MM, +0.4% vs. 1Q15, as-reported.
Copy to clipboard 
